BlossomHill Share Price
NASDAQ: BLSM | HealthcareBlossomHill Stock Performance
BlossomHill Share Price Today
As of 19 November 2026, BlossomHill Therapeutics, Inc.'s share price is $14.74. The stock opened at $14.68, compared to its previous close of $15.16. During today's trading session, BlossomHill Therapeutics, Inc.'s share price traded between $14.52 and $16.45, with an average price of $15.48. Over the past 52 weeks, the stock has recorded a high of $27.75 and a low of $11.02. In terms of performance, BlossomHill Therapeutics, Inc.'s share price has declined by 25.29% over the last six months and is down 25.29% on a year-on-year basis.
BlossomHill Share Price Chart
About BlossomHill
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.
BlossomHill Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $13.21 | $14.69 | +6.88% |
Oct 2026 | $18.70 | $13.74 | -26.46% |
Sep 2026 | $18.58 | $18.69 | -5.27% |
Aug 2026 | $15.79 | $19.73 | N/A |